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Abstract A potassium channel toxin (AeK) was isolated from
the sea anemone Actinia equina by gel filtration on Sephadex
G-50 and reverse-phase HPLC on TSKgel ODS-120T. AeK and
K-dendrotoxin inhibited the binding of 125I-K-dendrotoxin to rat
synaptosomal membranes with IC50 of 22 and 0.34 nM,
respectively, indicating that AeK is about sixty-five times less
toxic than K-dendrotoxin. The complete amino acid sequence of
AeK was elucidated; it is composed of 36 amino acid residues
including six half-Cys residues. The determined sequence showed
that AeK is analogous to the three potassium channel toxins from
sea anemones (BgK from Bunodosoma granulifera, ShK from
Stichodactyla helianthus and AsKS from Anemonia sulcata),
with an especially high sequence homology (86%) with AsKS.
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1. Introduction
Sea anemones are well known to contain two classes of
toxins (15^21 kDa hemolysins [1] and 3^5 kDa sodium chan-
nel toxins [1^4]) and about 6 kDa serine protease inhibitors
mostly belonging to the Kunitz-type family [5^10]. Besides
these biologically active substances, the following six potassi-
um channel toxins were recently isolated from three species of
sea anemones and characterized: BgK from Bunodosoma
granulifera [11], ShK from Stichodactyla helianthus [12] and
kaliseptine (AsKS) and three kalicludines (AsKC1^3) from
Anemonia sulcata [13]. These toxins behave as blockers of
voltage-sensitive potassium channels, similar to dendrotoxins
from mamba snakes [14], mast cell degranulating peptide from
the honeybee [15] and noxiustoxin from the Mexican scorpion
[16]. Based on the determined amino acid sequences, they can
be divided into two groups, group 1 toxins (BgK, ShK and
AsKS) composed of 35^37 amino acid residues and group 2
toxins (AsKC1^3) of 58 or 59 residues. The group 1 toxins are
a new family of potassium channel toxins in that their amino
acid sequences are entirely di¡erent from those of the known
voltage-sensitive potassium channel toxins from other sources,
thereby being expected to be useful tools for studies on the
structure and function of potassium channels. On the other
hand, the group 2 toxins seem to be none other than Kunitz-
type protease inhibitors. In fact, they have been shown to
have high sequence homologies with the known Kunitz-type
protease inhibitors and to exhibit antitryptic activity as well as
potassium channel toxicity [13].
In our recent screening, the aqueous extract of Actinia equi-
na, a relatively small species found in coastal waters of Japan,
was established to display potassium channel toxicity [17].
None of the four Kunitz-type protease inhibitors so far dis-
covered in A. equina were shown to be responsible for the
potassium channel toxicity observed. Instead, a potassium
channel toxin (named AeK) was isolated and demonstrated
to belong to the group 1 family. The present paper deals with
the isolation and primary structure of AeK from A. equina.
2. Materials and methods
2.1. Sea anemone
Specimens of A. equina were captured at Katsuura, Chiba Prefec-
ture, in April 1997. They were transported alive in sea water to our
laboratory and stored at 320‡C until used.
2.2. Isolation procedure
Frozen samples (ten specimens, 33 g) were thawed and extracted
with ¢ve volumes of distilled water. The extract was applied to a
Sephadex G-50 column (2.5U95 cm; Pharmacia, Uppsala, Sweden),
which was eluted with 0.15 M NaCl in 0.01 M phosphate bu¡er (pH
7.0). Fractions of 8 ml were collected and measured for absorbance at
280 nm and potassium channel toxicity. Toxin-containing fractions
were combined and then subjected to reverse-phase HPLC on a
TSKgel ODS-120T column (0.46U25 cm; Tosoh, Tokyo, Japan).
Elution was achieved at a £ow rate of 1 ml/min by a linear gradient
of acetonitrile (0^17.5% in 60 min) in 0.1% tri£uoroacetic acid (TFA).
Peptides were monitored at 220 nm with a UV detector. The elute
showing toxicity was manually collected and lyophilized. Thus, the
dried material was used as the puri¢ed toxin (AeK) in subsequent
experiments.
2.3. Assay for potassium channel toxicity
Potassium channel toxicity was indirectly assayed by competitive
inhibition of the binding of 125I-K-dendrotoxin, a potent potassium
channel toxin from the green mamba Dendroaspis angusticeps, to rat
synaptosomal membranes, essentially according to the method of
Harvey et al. [18]. Rat brains were purchased from Funakoshi
(Tokyo, Japan), K-dendrotoxin from Sigma (St. Louis, USA) and
125I-K-dendrotoxin with a speci¢c radioactivity of 2000 Ci/mmol
from Amersham (Tokyo, Japan). Rat synaptosomal membranes
were suspended in synaptosomal bu¡er (130 mM NaCl, 3 mM KCl,
2 mM CaCl2, 2 mM MgCl2 and 20 mM Tris-HCl, pH 7.4) at a
concentration of 0.25 mg protein/ml. For competitive binding experi-
ments, 0.2 ml of the synaptosomal membrane suspension was incu-
bated with 0.04 ml of sample solution and 0.01 ml of 125I-K-dendro-
toxin (20 pM in the synaptosomal bu¡er) at room temperature for
30 min. Then, the membranes were collected by centrifugation and
washed three times with 1 ml of the synaptosomal bu¡er containing
bovine serum albumin (1 mg/ml). The radioactivity bound to the
membranes was measured on a gamma counter (COBRA II; Packard,
Meriden, USA). Non-speci¢c binding (below 10%) was determined in
the presence of 0.56 WM K-dendrotoxin, instead of sample, and sub-
tracted from each datum.
2.4. Protein determination
Protein was determined by the method of Lowry et al. [19], using
bovine serum albumin as a standard.
2.5. Molecular weight determination
The molecular weight of the isolated toxin was determined by ma-
trix assisted laser desorption ionization/time of £ight mass spectrom-
etry (MALDI/TOFMS) with a Shimadzu/Kratos Kompact MALDI I
instrument. Sinapinic acid was used as a matrix.
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2.6. Sequence analysis
Sequence analyses were performed by the Edman degradation
method with an automatic gas-phase protein sequencer (LF-3400D
TriCart with high sensitivity chemistry; Beckman, Fullerton, USA).
3. Results and discussion
A potassium channel toxin (AeK) inhibiting the binding of
125I-K-dendrotoxin to rat synaptosomal membranes was iso-
lated from A. equina by gel ¢ltration on Sephadex G-50 and
reverse-phase HPLC on TSKgel ODS-120T. In gel ¢ltration,
AeK was eluted between fractions 49 and 55 (Fig. 1A). Sub-
sequent reverse-phase HPLC a¡orded two signi¢cant peaks at
retention times of 49 min and 53 min, of which the latter peak
contained AeK (Fig. 1B). Thus, 100 Wg of AeK was obtained
from 33 g of the starting material. In our binding experiments,
AeK as well as K-dendrotoxin blocked the binding of 125I-K-
dendrotoxin to rat synaptosomal membranes in a dose-de-
pendent manner (Fig. 2). The IC50 (50% inhibitory concen-
tration) values were estimated to be 22 nM for AeK and 0.34
nM for K-dendrotoxin, implying that AeK is about sixty-¢ve
times less potent than K-dendrotoxin.
Analysis by a sequencer determined the complete amino
acid sequence of AeK comprising 36 residues as shown in
Fig. 3. No impurities were detected in each cycle of the se-
quencing, demonstrating the homogeneity of the isolated tox-
in. The accuracy of the determined sequence of AeK was
supported by the following two criteria: (1) no increased ami-
no acid residues appeared in and after the 37th cycle of the
sequencing; and (2) the molecular weight (3954) of AeK cal-
culated from the determined sequence was consistent with that
(3954) estimated by MALDI/FOFMS.
As described in Section 1, the potassium channel toxins so
far isolated from sea anemones are divided into two groups
according to their chain length and sequence homology. Un-
equivocally, AeK is structurally analogous to BgK from B.
granulifera [11], ShK from S. helianthus [12] and AsKS from
A. sulcata [13], being a new member of the group 1 family
(Fig. 3). The sequence homology of AeK with AsKS is as high
as 86%, while those with BgK and ShK are moderate (53%
with BgK and 36% with ShK). Importantly, AeK has six half-
Cys residues at the same positions as the known group 1
toxins. This strongly suggests that the three disul¢de bonds
of AeK, though not assigned in this study, are located be-
tween Cys-2 and -36, Cys-11 and -29 and Cys-20 and -33,
as previously reported for BgK [20] and ShK [21]. Further-
more, it is interesting to note that the two amino acid residues
(Lys-22 and Tyr-23), which have been assumed to be the most
essential residues for the binding of ShK with potassium chan-
nels [22], are conserved in AeK as well as BgK and AsKS.
Previous binding experiments, using both or at least one of
125I-K-dendrotoxin and 125I-dendrotoxin I as labeled toxins,
con¢rmed that BgK [11,20] and ShK [12] are comparable in
potassium channel toxicity to dendrotoxins, while the toxicity
of AsKS is much less potent than dendrotoxins [13]. AeK, like
AsKS, was shown to be remarkably less toxic than K-dendro-
toxin in this study. This similarity in toxicity between AeK
and AsKS coincides well with the fact that the sequence ho-
mology of AeK with AsKS is especially high compared to
those with BgK and ShK. The low toxicity may be just
what makes AeK as well as AsKS useful in studying the
structure-activity relationship among the group 1 potassium
channel toxins.
In relation to the sequence similarity between the group 2
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Fig. 1. Isolation of AeK. A: Gel ¢ltration on Sephadex G-50. AeK-
containing fractions are indicated by a bar. B: Reverse-phase HPLC
on a TSKgel ODS-120T. AeK was eluted in the peak at a retention
time of 53 min, as indicated by an arrow.
Fig. 2. Inhibition of the binding of 125I-K-dendrotoxin to rat synap-
tosomal membranes by AeK and K-dendrotoxin. Each point repre-
sents the mean of two determinations.
Fig. 3. Alignment of the amino acid sequence of AeK with those of
the known sea anemone potassium channel toxins. BgK from Buno-
dosoma granulifera ; ShK from Stichodactyla helianthus ; AsKS from
Anemonia sulcata. The residues identical with AeK are boxed.
S. Minagawa et al./FEBS Letters 427 (1998) 149^151150
toxins (AsKC1^3 from A. sulcata) and Kunitz-type protease
inhibitors, it should be pointed out that four Kunitz-type in-
hibitors have previously been isolated from A. equina and two
of them completely sequenced [8]. None of the A. equina in-
hibitors, however, were obtained as potassium channel block-
ers in this study, suggesting that their toxicity, if any, is con-
siderably weak as demonstrated for AsKC1^3 [13]. In order to
discuss the biological function of Kunitz-type protease inhib-
itors, those from sea anemones including A. equina should be
evaluated for potassium channel toxicity by using their pure
preparation.
In conclusion, AeK isolated from A. equina is the fourth
member of the group 1 potassium channel toxins from sea
anemones. Our screening data [17] and those of Harvey et
al. [23] suggest a wider distribution of potassium channel tox-
ins in sea anemones. Further isolation and elucidation of sea
anemone potassium channel toxins should be continued, since
sea anemones may represent a new source of diverse potassi-
um channel toxins.
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